Grupo Aval Acciones Y Valores S.A.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Net income before income tax of continuing operations $5.6t $1.6b $2.3b $7.5t $6.5t $8.5t $6.3t $3.4t $3.1t $4.6t
Net Income $2.5t $739.0b $1.0t $1.7t
Net Income From Continuing Operations $6.3t $3.4t $3.1t $4.6t
Other Adjustments To Reconcile Profit Loss $6.2b $0
Increase (decrease) in cash and cash equivalents from continuing operations ($92.0b) $48.2m $1.9b $1.7t $3.9t $2.6t ($19.6t) $1.6t ($1.6t) $2.4t
Depreciation of tangible assets and right-of-use assets $455.9b $155.5m $147.3m $839.1b $921.7b $886.9b $559.9b $557.1b $588.3b $597.9b
Amortization of intangible assets $323.7b $146.7m $147.3m $459.6b $479.9b $559.4b $530.6b $594.1b $686.3b $767.9b
Amortization Cash Flow $530.6b $580.0b $674.3b $767.9b
Amortization Of Intangibles $530.6b $580.0b $674.3b $767.9b
Depreciation $559.9b $531.4b $561.8b $597.9b
Depreciation Amortization Depletion $1.1t $1.1t $1.2t $1.4t
Adjustments For Deferred Tax Of Prior Periods ($13.4b) ($117.6b) ($74.2b) ($86.5b) $7.9b $34.6b $7.9b ($165.0m) $9.6b
Impairment losses on loans and other accounts receivable $3.0t $1.4b $1.3b $4.2t $6.3t $4.6t $3.2t $4.8t $4.8t $4.3t
Loss on sale of investment property $12.0b $16.9b $10.0b $17.3b $22.2b $14.4b $28.4b
Earnings (Loss)es From Equity Investments ($372.8b) ($371.4b) ($378.4b) ($350.9b)
Additional Financial Items
Parent Company ($2.1t) ($2.0t) $1.8t $2.2t $2.3t $2.1t $669.8b $2.0t $1.2t
Adjustments For Current Tax Of Prior Period ($16.9b) ($52.5b) ($103.5b) ($35.6b) ($20.5b) ($12.6b)
Adjustments For Decrease Increase In Trade Account Receivable ($414.7b) ($269.8m) ($194.0m) ($374.4b) ($95.7b) ($621.2b) ($2.4t) ($975.7b) ($719.9b)
Adjustments For Unrealised Foreign Exchange Losses Gains $248.0b ($33.2m) $79.5m $109.5b ($68.1b) ($87.2b) $1.8t ($2.3t) $454.8b
General And Administrative Expense $645.7b $659.3b $487.5b $647.4b $843.1b $989.3b $940.8b
Goodwill $6.8t $2.3b $2.3b $7.3t $7.7t $8.5t $2.2t $2.2t $2.2t
Interest Received Classified As Operating Activities $12.8t $6.1b $5.4b $18.5t $18.2t $19.4t $16.9t $26.1t $28.0t
Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets $4.4b
Purchase Of Intangible Assets Classified As Investing Activities $183.7b $90.1m $119.7m $377.5b $559.0b $569.9b $598.2b $683.5b $658.6b
Net interest income ($9.2t) ($3.5b) ($3.3b) ($11.3t) ($12.0t) ($12.7t) ($7.7t) ($6.3t) ($7.3t) ($7.9t)
Accrued dividends ($28.0b) ($50.4b) ($22.0m) ($84.7b) ($91.6b) ($159.1b) ($119.9b) ($126.3b) ($148.5b) ($126.7b)
Net gains on sales of non-current assets held for sale ($20.7b) ($2.2m) ($4.6m) ($19.0b) ($108.6b) ($33.0b) ($9.7b) ($48.0b) ($21.5b) ($9.9b)
Gain on sale biological assets ($10.5b) ($9.4b) ($5.2b)
Valuations and interest from concession agreements ($181.0b) ($209.9b) ($979.0m) ($4.0t) ($3.7t) ($4.2t) ($5.1t) ($3.9t) ($2.9t) ($2.8t)
Foreign exchange (gains) losses $248.0b ($33.2m) $79.5m $109.5b ($68.1b) ($87.2b) $1.8t ($2.3t) $454.8b ($585.0b)
Profit of equity accounted on investments in associates and joint ventures ($140.8b) ($57.6m) ($60.8m) ($229.6b) ($220.2b) ($300.2b) ($372.8b) ($371.4b) ($378.4b) ($350.9b)
Derivatives ($228.1b) ($55.3m) ($131.5m) ($142.1b) ($669.3b) ($798.2b) ($1.5t) ($2.1t) $238.5b ($550.9b)
Non-current assets held for sale $0 $3.8m $7.7m ($2.3b) $1.3b $3.9b $76.0m $268.0m $4.7b $1.6b
Investment properties ($53.7b) ($15.6m) ($12.1m) ($19.6b) $46.9b ($22.8b) ($55.9b) ($85.0b) ($35.8b) ($68.3b)
Biological assets ($14.6b) ($4.5m) ($6.3m) ($18.9b) ($15.0b) ($28.5b) ($56.9b) ($18.6b) ($7.6b) ($3.4b)
Trading assets $3.1t $2.3t $218.3m ($584.6b) ($1.1t) $696.8b $545.5b ($2.8t) ($5.6t) ($6.8t)
Accounts receivable ($414.7b) ($269.8m) ($194.0m) ($374.4b) ($95.7b) ($621.2b) ($2.4t) ($975.7b) ($719.9b) ($892.4b)
Other assets $179.8b $42.6m $4.2m ($242.1b) ($621.0b) ($313.5b) $121.8b ($78.3b) ($136.8b) ($6.7b)
Other liabilities and provisions ($381.6b) $93.7m $848.6m $143.1b $247.0b $1.9t $462.9b $1.4t $1.1t $2.7t
Employee benefits $45.1b $15.6m $13.1m ($94.0b) ($49.5b) ($8.4b) $7.9b ($27.5b) $49.2b ($12.9b)
Loans ($10.4t) ($4.9b) ($2.5b) ($8.7t) ($11.2t) ($16.0t) ($27.8t) ($7.6t) ($14.0t) ($17.7t)
Customer deposits $9.7t $3.8b $1.2b $10.4t $24.6t $6.9t $17.8t $15.4t $14.8t $24.8t
Interbank borrowings and overnight funds ($3.4t) ($489.9m) $527.0m $2.4t ($2.7t) $3.2t ($1.4t) $5.9t $3.3t $4.9t
Borrowings from banks and others $146.7b $172.4m $456.1m ($3.2t) ($3.8t) $3.5t $8.7t ($3.9t) ($1.2t) $931.8b
Interest received $12.8t $6.1b $5.4b $18.5t $18.2t $19.4t $16.9t $26.1t $28.0t $23.4t
Discontinued operation ($17.6t) $1.4t ($2.2b) $37.8b
Acquisition of investment property ($56.6b) ($25.4m) ($16.7m) ($2.4b) ($1.7b) ($876.0m) ($2.3b) ($163.0m) ($793.0m) ($8.3b)
Additions of cost of biological assets ($21.4b) ($8.2m) ($6.4m) ($20.6b) ($21.3b) ($27.2b) ($28.4b) ($26.1b) ($26.6b) ($27.2b)
Concession contracts ($994.6b) $452.6b $853.8b $305.7b $158.8b
Additions of others intangibles assets ($183.7b) ($90.1m) ($119.7m) ($377.5b) ($559.0b) ($569.9b) ($598.2b) ($683.5b) ($658.6b) ($660.3b)
Acquisition of investments at FVOCI ($16.4t) ($25.4t) ($34.3t) ($41.3t) ($21.0t) ($24.4t) ($15.4t) ($17.5t)
Proceeds from sale of biological assets $20.7b $6.6m $9.9m $41.1b $48.2b $58.1b $40.6b $37.1b $35.9b $38.7b
Proceeds from sale of non-current assets held for sale $151.4b $28.6m $20.5m $154.6b $267.3b $76.8b $41.6b $61.7b $49.7b $75.2b
Purchases of financial assets at amortized cost ($2.7t) ($1.2b) ($1.2b) ($3.7t) ($6.5t) ($5.7t) ($6.9t) ($8.0t) ($7.8t) ($7.0t)
Redemptions of financial assets at amortized cost $2.7t $1.1b $1.2b $3.6t $4.3t $6.6t $6.4t $8.2t $8.3t $8.7t
Acquisition of investments in associates ($2.8b) ($5.3b) ($4.5b) ($7.3b) ($2.4b) ($2.5b)
Capitalized leasing cost $1.4b ($137.0m) ($690.0m) ($132.0m) ($335.0m) ($282.0m)
Payment of obligations under financial lease ($362.3b) ($429.6b) ($472.1b) ($383.5b) ($391.7b) ($416.6b) ($429.5b)
Equity transaction ($67.2b) ($67.1b) ($51.0b) $120.0m ($15.0b) ($55.0b) ($6.0m)
Beginning Cash Position $36.6t $17.0t $18.6t $17.0t
Cash Flow From Continuing Financing Activities ($8.6t) ($4.9t) ($1.4t) ($2.7t)
Cash Flow From Continuing Investing Activities $4.6t $1.5t ($2.9t) ($2.3t)
Cash From Discontinued Financing Activities $1.4t ($2.2b) $37.8b
Cash From Discontinued Investing Activities ($17.6t) $331.1b ($202.6b) $895.6b
Change In Other Current Assets $121.8b ($101.4b) ($138.0b) ($6.7b)
Change In Other Current Liabilities $462.9b $1.5t $1.1t $2.7t
Change In Other Working Capital $19.8t $9.2t $9.1t $17.5t
Change In Receivables ($2.4t) ($1.2t) ($792.5b) ($892.4b)
Change In Working Capital ($2.1t) $7.1t ($2.2t) $7.5t
Changes In Account Receivables ($1.2t) ($792.5b) ($892.4b)
Changes In Cash ($21.8t) $4.3t ($3.7t) $3.3t
End Cash Position $17.0t $18.6t $17.0t $19.4t
Financing Cash Flow ($8.6t) ($3.5t) ($1.4t) ($2.7t)
Free Cash Flow ($1.4t) $4.7t ($521.2b) $6.1t
Gain Loss On Sale Of PPE ($153.3b) ($355.8b) ($84.7b) ($137.0b)
Interest Received CFO $16.9t $24.9t $26.8t $23.4t
Investing Cash Flow ($13.0t) $1.8t ($3.1t) ($1.4t)
Issuance Of Capital Stock $120.0m $0
Net Business Purchase And Sale $0 ($2.3b) $0 $0
Net Foreign Currency Exchange Gain Loss $1.8t ($2.3t) $452.6b ($585.0b)
Net Intangibles Purchase And Sale ($145.6b) $177.0b ($347.0b) ($501.5b)
Net PPE Purchase And Sale ($446.4b) ($511.1b) ($546.9b) ($449.9b)
Net Preferred Stock Issuance ($29.8b) $0 $0
Operating Gains Losses ($398.4b) ($635.9b) ($608.3b) ($991.7b)
Other Cash Adjustment Outside Changein Cash ($1.4t) $201.0m $0 $401.1b
Other Non Cash Items ($12.9t) ($9.8t) ($9.8t) ($10.7t)
Preferred Stock Payments ($29.8b) $0 $0
Purchase Of Business $0 ($2.3b) $0 $0
Purchase Of Intangibles ($598.2b) ($676.8b) ($652.7b) ($660.3b)
Purchase Of PPE $158.8m $168.9m $679.0b $638.3b $664.5b ($519.4b) ($579.6b) ($623.9b) ($602.3b)
Repurchase Of Capital Stock ($15.0b) $0 ($55.0b) ($6.0m)
Sale Of Intangibles $452.6b $853.8b $305.7b $158.8b
Sale Of PPE $73.0b $68.5b $77.0b $152.4b
Profit or Loss $3.5t $1.1b $1.6b $5.4t $4.6t $5.7t $4.9t $2.2t $2.2t
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $241.6b $23.4m $17.3m $77.1b $41.9b $76.7b $73.0b $76.7b $78.5b $152.4b
Capital Expenditure ($1.1t) ($1.3t) ($1.3t) ($1.3t)
Capital Expenditure Reported ($29.1b) ($26.2b) ($26.9b) ($27.5b)
Net Investment Properties Purchase And Sale $74.0b $111.4b $65.6b $199.7b
Net Investment Purchase And Sale $4.6t $1.2t ($2.6t) ($2.1t)
Purchase Of Investment ($27.9t) ($31.8t) ($22.5t) ($24.5t)
Purchase Of Investment Properties ($2.3b) ($163.0m) ($793.0m) ($8.3b)
Proceeds from sale of investments at FVOCI $14.4t $23.4t $31.4t $35.5t $23.5t $25.7t $12.0t $13.7t
Proceeds from sale of investment properties $61.8b $9.5m $24.9m $57.0b $110.8b $67.5b $76.3b $111.5b $66.4b $207.9b
Sale Of Investment $32.5t $33.0t $19.9t $22.4t
Sale Of Investment Properties $76.3b $111.5b $66.4b $207.9b
Net Other Investing Changes $82.3b $86.5b $73.7b $113.9b
Net cash (used in) provided by investing activities ($952.9b) ($1.2b) ($937.7m) ($3.1t) ($7.6t) ($6.6t) ($13.0t) $1.8t ($3.1t) ($1.4t)
Cash flows from financing activities:
Issuance of debt securities $5.8t $1.5b $337.2m $3.1t $5.7t $2.9t $695.1b $2.6t $2.3t $528.9b
Issuance Of Debt $695.1b $1.1t $2.2t $528.9b
Long Term Debt Issuance $695.1b $1.1t $2.2t $528.9b
Net Issuance Payments Of Debt ($7.5t) ($3.2t) $89.7b ($1.4t)
Net Long Term Debt Issuance ($7.5t) ($3.2t) $89.7b ($1.4t)
Payment of outstanding debt securities ($3.7t) ($1.3b) ($350.8m) ($1.5t) ($2.2t) ($1.6t) ($7.8t) ($4.1t) ($1.8t) ($1.5t)
Long Term Debt Payments ($7.8t) ($4.3t) ($2.1t) ($1.9t)
Repayment Of Debt ($7.8t) ($4.3t) ($2.1t) ($1.9t)
Common Stock Issuance $120.0m $0
Net Common Stock Issuance ($15.0b) $0 ($55.0b) ($6.0m)
Common Stock Payments ($15.0b) $0 ($55.0b) ($6.0m)
Dividends paid ($2.1t) ($2.0t) $1.8t $2.2t $2.3t $2.1t $669.8b $2.0t $1.2t
Dividends Paid Classified As Financing Activities $1.3t $438.2m $347.3m $1.3t $1.3t $1.2t $414.3b $766.5b $728.2b
Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners $1.1t $1.3t $1.2t $1.2t $1.0t $1.0t $569.8b
Dividends received from investments $125.3b $57.4m $63.6m $307.6b $389.6b $369.0b $411.4b $477.6b $445.6b $444.4b
Dividends paid to shareholders ($1.3t) ($438.2m) ($347.3m) ($1.3t) ($1.3t) ($1.2t) ($414.3b) ($766.5b) ($728.2b) ($625.8b)
Cash Dividends Paid ($414.3b) ($766.5b) ($728.2b) ($625.8b)
Dividends Received CFI $411.4b $471.3b $439.0b $444.4b
Net Other Financing Charges ($615.2b) ($915.9b) ($667.3b) ($662.3b)
Effect Of Exchange Rate Changes $3.6t ($2.7t) $2.1t ($1.3t)
Effect of foreign currency changes on cash and cash equivalents ($1.7t) $30.8m $424.0m $40.5b $1.1t $4.7t $3.6t ($2.7t) $2.1t ($1.3t)
Cash and cash equivalents from non-current assets classified as held for sale $201.0m $401.1b
Cash and cash equivalents at beginning of year $7.4b $7.5b $8.7b $30.1t $34.0t $36.6t $17.0t $18.6t $17.0t $19.4t
Change In Cash Supplemental As Reported ($19.6t) $1.6t ($1.6t) $2.4t
Interest Paid Classified As Operating Activities $7.4t $2.8b $2.2b $7.9t $8.7t $7.1t $10.6t $21.5t $21.4t ($662.3b)
Income Taxes Paid Refund Classified As Operating Activities $1.1t $527.2m $451.4m $1.6t $1.7t $1.7t $1.5t $2.0t $2.0t ($2.2t)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.